Form 4 for TXG 10x Genomics, Inc.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001610717-25-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-03-04 | 2025-03-04 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $1.20 | +50.0K | 921.5K | +6% | +$60.0K |
| DT | 2025-03-04 | 2025-02-28 | TXG | Saxonov Serge | CEO, Dir | S - Sale+OE | $10.63 | -7,942 | 871.5K | -0.9% | -$84.4K |
| DT | 2025-03-04 | 2025-03-04 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $0.00 | -50.0K | 17.5K | -74% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-03-04 | M | A | 50,000 | $1.20 | 921,540 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-02-28 | S | D | 7,942 | $10.63 | 871,540 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $10.415 to $10.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Derivative | Stock Option (right to buy) | 2025-03-04 | M | D | 50,000 | $0.00 | 17,463 | D | $1.20 · — to 2027-10-18 | 50,000 Class A Common Stock | (F7) This option, originally for 300,000 shares, of which 282,537 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and was fully vested as of October 1, 2021. |